Anzeige
Mehr »
Login
Freitag, 01.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Neuer Gold Rekord bei knapp 2.800 USD und Übernahme-Zirkus!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
260 Leser
Artikel bewerten:
(0)

MedQuist Ranked Number One in Front-End Speech Recognition in Top 20: 2006 Best in KLAS' Report Issued 12/15/06


MOUNT LAUREL, N.J., Dec. 20 /PRNewswire-FirstCall/ -- MedQuist Inc. (Pink Sheets: MEDQ) is pleased to announce that its SpeechQ for Radiology(TM) product was again rated number one for front-end speech recognition by customers, according to KLAS Enterprises' "Top 20: 2006 Best in KLAS Awards" Report.(1) The SpeechQ for Radiology solution first qualified for a KLAS review in early 2006 and was subsequently ranked as the number one solution in front-end speech recognition in the KLAS Enterprises Speech Recognition Report published on April 28, 2006.

"It's very gratifying to know that SpeechQ for Radiology continues to be highly valued by our customers," says Scott Bennett, MedQuist's senior vice president of Sales and Marketing. "We have experienced a lot of success with our speech recognition solutions over the past 18 months. Many of our customers have used other speech recognition products and tell us that our solutions provide them with superior workflow and accuracy, which allows them to be more productive."

KLAS regularly surveys and interviews more than 4,500 hospitals to develop an extensive database of various healthcare vendors' products and services, including information on vendor installation and post-live support, as well as success indicators and business indicators.


SpeechQ, which is powered by an embedded Philips SpeechMagic(TM) engine, allows physicians to easily become proficient with speech recognition technology within a few hours of use. Dr. William Keyes, a neuroradiologist at Inland Imaging, LLC in Spokane, Washington, who often interprets radiology exams for emergency room patients, observes, "It is not unusual for my final report to be printing in the ED before the patient has even been transported back to the department. Before implementing SpeechQ for Radiology, I would have to relay my preliminary findings verbally by telephone or by a handwritten fax." He adds, "My reports are more accurate since I am able to create a final report while my patients' images are displayed, and I now have more time for actually viewing the images."

About MedQuist

MedQuist, a member of the Philips Group of Companies, is a leading provider of clinical documentation workflow solutions in support of the electronic health record. MedQuist provides electronic medical transcription, health information and document management products and services, including digital dictation, speech recognition, Web-based transcription, electronic signature, medical coding, mobile dictation devices, and outsourcing services.

About KLAS

KLAS began to measure and report Healthcare Information Technology (HIT) vendor performance in 1996. To candidly gather performance ratings, KLAS confidentially interviews thousands of professionals in healthcare annually. The result of the interviews is an extensive HIT performance database representing over 4,500 healthcare facilities and 500 products. Vendors, consultants, investment bankers and healthcare providers use KLAS performance reports. For more information, contact KLAS Enterprises, LLC at 800-920-4109 or visit the KLAS web site at http://www.healthcomputing.com/.

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. Such risks and uncertainties, which could cause actual results to differ from those contained in forward-looking statements include, but are not limited to: (1) our ability to recruit and retain qualified transcriptionists and other employees; (2) the impact of new services or products on the demand for our existing services; (3) our current dependence on medical transcription for substantially all of our business; (4) our ability to expand our customer base; (5) changes in law, including, without limitation, the impact the Health Insurance Portability and Accountability Act (HIPAA) will have on our business; (6) infringement on the proprietary rights of others; (7) risks inherent in diversifying into other businesses; (8) any continuation of pricing pressures and declining billing rates; (9) difficulties relating to the implementation of management changes throughout the Company; (10) the outcome of pending and future legal and regulatory proceedings and investigations; and (11) any direct or indirect impact of the matters disclosed in the Form 8-K filed by the Company on November 9, 2006. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward- looking statements, whether as a result of new information, future events or otherwise.

(1) (C) Copyright 2006 KLAS Enterprises. All rights reserved.
© 2006 PR Newswire
Nach Nvidia: 5 KI-Revolutionäre aus der zweiten Reihe!
Künstliche Intelligenz hat spätestens nach dem Raketenstart von Chat GPT das Leben aller verändert. Doch der Superzyklus steht nach Meinungen von Experten erst am Anfang. Während Aktien wie Nvidia von der ersten Aufwärtsentwicklung stark profitieren konnten, versprechen aussichtsreiche Player aus der

zweiten Reihe noch enormes Aufwärtspotenzial.

Im kostenlosen, exklusiven Spezialreport präsentieren wir ihnen 5 innovative KI-Unternehmen, die bahnbrechende Entwicklungen in diesem Sektor prägen könnten.

Warum sollten Sie dabei sein?
Trotz der jüngsten Erfolge steht die Entwicklung der künstlichen Intelligenz noch am Beginn eines neuen Superzyklus. Experten gehen davon aus, dass der Sektor bis 2032 global auf 1,3 Billionen US-Dollar explodieren wird, wobei ein großer Teil auf Hardware und Infrastruktur entfallen wird.

Nutzen Sie die Chance!
Fordern Sie sofort unseren brandneuen Spezialreport an und erfahren Sie, welche 5 KI-Aktien das größte Potenzial zur Vervielfachung besitzen. Dieser Report ist komplett kostenlos und zeigt Ihnen die aussichtsreichsten Investments im KI-Sektor.
Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.